第十一届国际精神药理学大会暨第七届儿童与青少年精神药理学国际研讨会

IF 0.5 4区医学 Q4 PHARMACOLOGY & PHARMACY

Psychiatry and Clinical Psychopharmacology Pub Date : 2019-08-13 DOI:10.1080/24750573.2019.1606883

N. Müller

{"title":"第十一届国际精神药理学大会暨第七届儿童与青少年精神药理学国际研讨会","authors":"N. Müller","doi":"10.1080/24750573.2019.1606883","DOIUrl":null,"url":null,"abstract":"Selected publications: Müller N and Schwarz MJ. (2007) The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm (Suppl 72): 269-280. Müller N and Schwarz MJ. (2007) The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 1-13. (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo-controlled, add-on pilot study to reboxetine. Molecular Psychiatry 11: 680-684. (2002) Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"26 1","pages":"311 - 446"},"PeriodicalIF":0.5000,"publicationDate":"2019-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology\",\"authors\":\"N. Müller\",\"doi\":\"10.1080/24750573.2019.1606883\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Selected publications: Müller N and Schwarz MJ. (2007) The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm (Suppl 72): 269-280. Müller N and Schwarz MJ. (2007) The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 1-13. (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo-controlled, add-on pilot study to reboxetine. Molecular Psychiatry 11: 680-684. (2002) Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.\",\"PeriodicalId\":20847,\"journal\":{\"name\":\"Psychiatry and Clinical Psychopharmacology\",\"volume\":\"26 1\",\"pages\":\"311 - 446\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2019-08-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychiatry and Clinical Psychopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/24750573.2019.1606883\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry and Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/24750573.2019.1606883","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 2

摘要

入选出版物:m ller N和Schwarz MJ。(2007)精神分裂症中谷氨酸能紊乱的免疫学基础:一个综合的观点。中国生物医学工程学报(自然科学版)。m ller N和Schwarz MJ。(2007)免疫介导的血清素和谷氨酸的改变:对抑郁症的综合观点。Mol精神病学1-13。(2006)环氧化酶-2抑制剂塞来昔布对重度抑郁症有治疗作用:一项双盲、随机、安慰剂对照、利博西汀附加试验研究的结果。分子精神病学11:680-684。(2002)与利培酮单独治疗相比，塞来昔布辅助治疗对精神分裂症的有益抗精神病效果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology

Selected publications: Müller N and Schwarz MJ. (2007) The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm (Suppl 72): 269-280. Müller N and Schwarz MJ. (2007) The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 1-13. (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo-controlled, add-on pilot study to reboxetine. Molecular Psychiatry 11: 680-684. (2002) Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Psychiatry and Clinical Psychopharmacology Medicine-Psychiatry and Mental Health

CiteScore

1.00

自引率

14.30%

发文量

期刊介绍： Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences.